Cargando…

The effect of the third dose of the BNT162b2 vaccine on anti-SARS-CoV-2 spike antibody levels in healthcare workers with and without COVID-19 infection

AIM: A third (booster) dose of the anti-SARS-CoV-2 vaccine became necessary due to the observed decrease in anti-SARS-CoV-2S antibody levels over time, new mutations, and low global vaccination rates. In this study, anti-SARS-CoV-2S antibody levels were measured (ECLIA assay) in 50 healthcare worker...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wolszczak-Biedrzycka, Blanka, Bieńkowska, Anna, Cieślikiewicz, Beata, Smolińska-Fijołek, Elwira, Biedrzycki, Grzegorz, Dorf, Justyna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Infectious Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970245/ https://www.ncbi.nlm.nih.gov/pubmed/36820816 http://dx.doi.org/10.1080/07853890.2023.2182907

Ejemplares similares

Anti-SARS-CoV-2S Antibody Levels in Healthcare Workers 10 Months after the Administration of Two BNT162b2 Vaccine Doses in View of Demographic Characteristic and Previous COVID-19 Infection
por: Wolszczak-Biedrzycka, Blanka, et al.
Publicado: (2022)

The Influence of Two Priming Doses of Different Anti-COVID-19 Vaccines on the Production of Anti-SARS-CoV-2 Antibodies After the Administration of the Pfizer/BioNTech Booster
por: Wolszczak Biedrzycka, Blanka, et al.
Publicado: (2022)

Assessment of Post-Vaccination Antibody Response Eight Months after the Administration of BNT1622b2 Vaccine to Healthcare Workers with Particular Emphasis on the Impact of Previous COVID-19 Infection
por: Wolszczak-Biedrzycka, Blanka, et al.
Publicado: (2021)

An Assessment of the Serum Activity of ADH and ALDH in Patients with Primary Biliary Cholangitis
por: Wolszczak-Biedrzycka, Blanka, et al.
Publicado: (2022)

Activity of Total Alcohol Dehydrogenase, Alcohol Dehydrogenase Isoenzymes and Aldehyde Dehydrogenase in the Serum of Patients with Alcoholic Fatty Liver Disease
por: Wolszczak-Biedrzycka, Blanka, et al.
Publicado: (2021)

Antioxidant and Anti-Glycation Potential of H2 Receptor Antagonists—In Vitro Studies and a Systematic Literature Review
por: Biedrzycki, Grzegorz, et al.
Publicado: (2023)

Three-month follow-up of durability of response to the third dose of the SARS-CoV-2 BNT162b2 vaccine in adults aged 60 years and older: a prospective cohort study
por: Eliakim-Raz, Noa, et al.
Publicado: (2022)

Intracranial Hemorrhage After Pfizer-BioNTech (BNT162b2) mRNA COVID-19 Vaccination: A Case Report
por: Yangi, Kivanc, et al.
Publicado: (2023)

Demographic and clinical characteristics associated with variations in antibody response to BNT162b2 COVID-19 vaccination among healthcare workers at an academic medical centre: a longitudinal cohort analysis
por: Ebinger, Joseph E, et al.
Publicado: (2022)

Factors associated with anti-SARS-CoV-2 antibody titres 3 months post-vaccination with the second dose of BNT162b2 vaccine: a longitudinal observational cohort study in western Greece
por: Parthymou, Anastasia, et al.
Publicado: (2022)

Adaptation of medical laboratory scientists to workplace hazards – experiences from the COVID-19 pandemic
por: Wolszczak-Biedrzycka, Blanka, et al.
Publicado: (2022)

Immunosuppression reduction when administering a booster dose of the BNT162b2 mRNA SARS-CoV-2 vaccine in kidney transplant recipients without adequate humoral response following two vaccine doses: protocol for a randomised controlled trial (BECAME study)
por: Yahav, Dafna, et al.
Publicado: (2021)

Immune thrombocytopenia in 2 healthy young women after the Pfizer‐BioNTech BNT16B2b2 messenger RNA coronavirus disease 2019 vaccination
por: Collins, Emilie C., et al.
Publicado: (2021)

Clinical Significance and Diagnostic Utility of NLR, LMR, PLR and SII in the Course of COVID-19: A Literature Review
por: Kosidło, Jakub Wiktor, et al.
Publicado: (2023)

The Diagnostic Value of Inflammatory Markers (CRP, IL6, CRP/IL6, CRP/L, LCR) for Assessing the Severity of COVID-19 Symptoms Based on the MEWS and Predicting the Risk of Mortality
por: Wolszczak-Biedrzycka, Blanka, et al.
Publicado: (2023)

Assessment of SARS-CoV-2-Infected Patients and Their Clinical Outcomes During the Third Wave in India: A Single-Center Observational Study
por: Shahapur, Praveen R, et al.
Publicado: (2022)

Probing the Increased Virulence of Severe Acute Respiratory Syndrome Coronavirus 2 B.1.617 (Indian Variant) From Predicted Spike Protein Structure
por: Hajj-Hassan, Houssein, et al.
Publicado: (2021)

SARS-CoV-2 Spike-specific IFN-γ T-cell Response After COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant
por: Imhof, Céline, et al.
Publicado: (2022)

Avoiding culture shock with the SARS-CoV-2 spike protein
por: Hale, Benjamin G
Publicado: (2021)

Conformational dynamics and allosteric modulation of the SARS-CoV-2 spike
por: Díaz-Salinas, Marco A, et al.
Publicado: (2022)

Neutrophil/Lymphocyte Ratio (NLR) and Lymphocyte/Monocyte Ratio (LMR) – Risk of Death Inflammatory Biomarkers in Patients with COVID-19
por: Dymicka-Piekarska, Violetta, et al.
Publicado: (2023)

Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2
por: Reiter, Rieke, et al.
Publicado: (2022)

Evolution of the COVID-19 Pandemic: An Analysis of the Brunt of the Second and Third Waves on Patients in Western Uttar Pradesh
por: Mishra, Prem P, et al.
Publicado: (2022)

CoronaVac or BNT162b2 Vaccine as a Third Dose
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Temocillin versus meropenem for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant Enterobacterales (ASTARTÉ): protocol for a randomised, pragmatic trial
por: Marín-Candón, Alicia, et al.
Publicado: (2021)

Lys417 acts as a molecular switch that regulates the conformation of SARS-CoV-2 spike protein
por: Geng, Qibin, et al.
Publicado: (2023)

Anti‐spike IgG antibody kinetics following the second and third doses of BNT162b2 vaccine in nursing home residents
por: Jeulin, Helene, et al.
Publicado: (2022)

Piperacillin–tazobactam versus meropenem for treatment of bloodstream infections caused by third-generation cephalosporin-resistant Enterobacteriaceae: a study protocol for a non-inferiority open-label randomised controlled trial (PeterPen)
por: Bitterman, Roni, et al.
Publicado: (2021)

Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection
por: Nemet, Ital, et al.
Publicado: (2021)

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update
por: Pal, Mahendra, et al.
Publicado: (2020)

Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT
por: Redjoul, Rabah, et al.
Publicado: (2021)

Favorable Humoral Response to Third Dose of BNT162b2 in Patients Undergoing Hemodialysis
por: Kitamura, Mineaki, et al.
Publicado: (2022)

Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine
por: Moreira, Edson D., et al.
Publicado: (2022)

Targeting 2-Oxoglutarate–Dependent Dioxygenases Promotes Metabolic Reprogramming That Protects against Lethal SARS-CoV-2 Infection in the K18-hACE2 Transgenic Mouse Model
por: Jessop, Forrest, et al.
Publicado: (2023)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Mimicking as Pulmonary Tuberculosis in an Inmate
por: Akbar, Hina, et al.
Publicado: (2020)

Predictive Factors for Humoral Response After 2-dose SARS-CoV-2 Vaccine in Solid Organ Transplant Patients
por: Marion, Olivier, et al.
Publicado: (2021)

Radiographic findings of SARS‐CoV‐2 infection
por: Marco, Catherine A., et al.
Publicado: (2021)

A multicentre observational study on neonates exposed to SARS-CoV-2 in China: the Neo-SARS-CoV-2 Study protocol
por: Xiao, Tiantian, et al.
Publicado: (2020)

Coinfection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Bordetella bronchiseptica Pneumonia in a Renal Transplant Patient
por: Nagarakanti, Sandhya, et al.
Publicado: (2021)

Effect of the third dose of BNT162b2 vaccine on quantitative SARS-CoV-2 spike 1–2 IgG antibody titers in healthcare personnel
por: Romero-Ibarguengoitia, Maria Elena, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pmpd5dd0pikbd8u70i800acan9